product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
eIF3C Antibody
catalog :
2068S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse, rat
application :
western blot
citations: 1
Published Application/Species/DilutionReference
Zeng L, Wan Y, Li D, Wu J, Shao M, Chen J, et al. The m subunit of murine translation initiation factor eIF3 maintains the integrity of the eIF3 complex and is required for embryonic development, homeostasis, and organ size control. J Biol Chem. 2013;288:30087-93 pubmed publisher
product information
SKU :
2068S
Product-Name :
eIF3C Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, Mk, (R)
Applications :
Western blot
Product-Category :
Translational Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
110
Host :
Rabbit
Target :
eIF3c
Primary-Protein :
eIF3C
Alt-Names :
EIF3C,EIF3CL,EIF3S8,Eukaryotic translation initiation factor 3 subunit 8,Eukaryotic translation initiation factor 3 subunit C,FLJ78287,MGC189744,cell migration-inducing protein 17,eIF3 p110,eIF3-p110,eukaryotic translation initiation factor 3, subunit 8 (110kD),eukaryotic translation initiation factor 3, subunit 8, 110kDa,eukaryotic translation initiation factor 3, subunit C
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.